Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea · Delayed Price · Currency is KRW 3,540.00
+40.00 (1.14%)
At close: Sep 8, 2025
Bukwang Pharmaceutical Market Cap
Bukwang Pharmaceutical has a market cap or net worth of 350.26 billion as of September 8, 2025. Its market cap has decreased by -3.82% in one year.
Market Cap
350.26B
Enterprise Value
291.34B
Revenue
179.16B
Ranking
n/a
PE Ratio
29.18
Stock Price
3,540.00
Market Cap Chart
Since August 29, 1995, Bukwang Pharmaceutical's market cap has increased from 63.76B to 350.26B, an increase of 449.38%. That is a compound annual growth rate of 5.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 349.27B | 11.16% |
| Dec 30, 2024 | 314.21B | -24.75% |
| Dec 28, 2023 | 417.57B | -30.29% |
| Dec 29, 2022 | 598.98B | -32.17% |
| Dec 30, 2021 | 883.07B | -54.11% |
| Dec 30, 2020 | 1,924.17B | 109.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.31T |
| Celltrion | 37.23T |
| ALTEOGEN | 25.41T |
| Yuhan | 8,902.27B |
| SK Biopharmaceuticals | 8,551.81B |
| Peptron | 7,070.75B |
| PharmaResearch | 6,545.48B |
| ABL Bio | 5,621.23B |